Suchergebnisse - "Kim, Tae Min"

PubPharm (883)

1

Ultra-fast Prediction of Somatic Structural Variations by Reduced Read Mapping via Pan-Genome k-mer Sets

enthalten in: bioRxiv.org | 2024

von Choi, M. | Sohn, J. | Yi, D. | +11

2

Clinical feasibility of deep learning-based synthetic CT images from T2-weighted MR images for cervical cancer patients compared to MRCAT

enthalten in: Scientific reports | 2024

von Kim, H. | Yoo, S. | Kim, J. | +12

3

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Park, S. | Kim, T. | Han, J. | +21

4

Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea

enthalten in: European journal of haematology | 2024

von Kim, D. | Youk, J. | Byun, J. | +7

5

Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis

enthalten in: Cancer research and treatment | 2024

von Park, C. | Kim, R. | Choi, J. | +5

6

Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell Lung Cancer : Implications for Thoracic Radiotherapy

enthalten in: Cancer research and treatment | 2024

von Kim, D. | Kim, H. | Wu, H. | +5

7

CRIF1 deficiency induces FOXP3LOW inflammatory non-suppressive regulatory T cells, thereby promoting antitumor immunity

enthalten in: Science advances | 2024

von Lee, S. | Song, S. | Kim, G. | +17

8

Matching-adjusted indirect comparison of amivantamab vs mobocertinib in platinum-pretreated EGFR Exon 20 insertion-mutated non-small-cell lung cancer

enthalten in: Future oncology (London, England) | 2024

von Kim, T. | Girard, N. | Leighl, N. | +10

9

High-resolution genomic configuration of FGFR rearrangements dictates the therapeutic vulnerability of squamous cell lung cancers

enthalten in: Translational lung cancer research | 2024

von Hong, S. | Kim, T.

CommentOn: J Clin Invest. 2023 Nov 1;133(21):. - PMID 37606995

10

CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors : a phase 2 randomized trial

enthalten in: Investigational new drugs | 2024

von Armstrong, A. | Geva, R. | Chung, H. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[89]